152 related articles for article (PubMed ID: 25456426)
1. Drynaria fortunei J. Sm. improves the bone mass of ovariectomized rats through osteocalcin-involved endochondral ossification.
Lee YE; Liu HC; Lin YL; Liu SH; Yang RS; Chen RM
J Ethnopharmacol; 2014 Dec; 158 Pt A():94-101. PubMed ID: 25456426
[TBL] [Abstract][Full Text] [Related]
2. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone.
Wong KC; Pang WY; Wang XL; Mok SK; Lai WP; Chow HK; Leung PC; Yao XS; Wong MS
Br J Nutr; 2013 Aug; 110(3):475-85. PubMed ID: 23302510
[TBL] [Abstract][Full Text] [Related]
3. A polysaccharide from the dried rhizome of Drynaria fortunei (Kunze) J. Sm. prevents ovariectomized (OVX)-induced osteoporosis in rats.
Sun X; Wei B; Peng Z; Chen X; Fu Q; Wang C; Zhen J; Sun J
J Cell Mol Med; 2020 Mar; 24(6):3692-3700. PubMed ID: 32065504
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats.
Zhang ZG; Bai D; Liu MJ; Li Y; Pan JH; Liu H; Wang WL; Xiang LH; Xiao GG; Ju DH
Menopause; 2013 Feb; 20(2):232-40. PubMed ID: 23096243
[TBL] [Abstract][Full Text] [Related]
5. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
6. [Research progress on Drynaria fortunei naringin on inflammation and bone activity].
Yin FM; Xiao LB; Zhang Y
Zhongguo Gu Shang; 2015 Feb; 28(2):182-6. PubMed ID: 25924506
[TBL] [Abstract][Full Text] [Related]
7. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
8. Drynaria fortunei J. Sm. promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults.
Hung TY; Chen TL; Liao MH; Ho WP; Liu DZ; Chuang WC; Chen RM
J Ethnopharmacol; 2010 Aug; 131(1):70-7. PubMed ID: 20554009
[TBL] [Abstract][Full Text] [Related]
9. Effects of yuja peel extract and its flavanones on osteopenia in ovariectomized rats and osteoblast differentiation.
Jeon EJ; Lee DH; Kim YJ; Ahn J; Kim MJ; Hwang JT; Hur J; Kim M; Jang YJ; Ha TY; Seo DH; Lee JS; Sung MJ; Jung CH
Mol Nutr Food Res; 2016 Dec; 60(12):2587-2601. PubMed ID: 27506630
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic effect of aqueous-extract from a traditional Chinese medical herb Drynaria fortunei on rat experimental model of alveolar bone resorption].
Chen LL; Tang Q; Yan J
Zhongguo Zhong Yao Za Zhi; 2004 Jun; 29(6):549-53. PubMed ID: 15706922
[TBL] [Abstract][Full Text] [Related]
11. A standardized phytopreparation from an Indian medicinal plant (Dalbergia sissoo) has antiresorptive and bone-forming effects on a postmenopausal osteoporosis model of rat.
Khedgikar V; Gautam J; Kushwaha P; Kumar A; Nagar GK; Dixit P; Chillara R; Voruganti S; Singh SP; Uddin W; Jain GK; Singh D; Maurya R; Chattopadhyay N; Trivedi R
Menopause; 2012 Dec; 19(12):1336-46. PubMed ID: 22850441
[TBL] [Abstract][Full Text] [Related]
12. The effect of Gu-Sui-Bu (Drynaria fortunei J. Sm) immobilized modified calcium hydrogenphosphate on bone cell activities.
Sun JS; Dong GC; Lin CY; Sheu SY; Lin FH; Chen LT; Chang WH; Wang YJ
Biomaterials; 2003 Feb; 24(5):873-82. PubMed ID: 12485805
[TBL] [Abstract][Full Text] [Related]
13. Onion decreases the ovariectomy-induced osteopenia in young adult rats.
Huang TH; Mühlbauer RC; Tang CH; Chen HI; Chang GL; Huang YW; Lai YT; Lin HS; Yang WT; Yang RS
Bone; 2008 Jun; 42(6):1154-63. PubMed ID: 18387868
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid and 17 beta-estradiol co-treatment is more effective than 17 beta-estradiol alone in maintaining bone post-ovariectomy.
Poulsen RC; Moughan PJ; Kruger MC
Exp Biol Med (Maywood); 2008 May; 233(5):592-602. PubMed ID: 18375826
[TBL] [Abstract][Full Text] [Related]
15. The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast MC3T3-E1 and in vivo bone formation in ovariectomized rats.
Zhao Y; Zou B; Shi Z; Wu Q; Chen GQ
Biomaterials; 2007 Jul; 28(20):3063-73. PubMed ID: 17418401
[TBL] [Abstract][Full Text] [Related]
16. Sevelamer restores bone volume and improves bone microarchitecture and strength in aged ovariectomized rats.
Sampath TK; Simic P; Moreno S; Bukanov N; Draca N; Kufner V; Tikvica A; Blair A; Semenski D; Brncic M; Burke SK; Vukicevic S
Endocrinology; 2008 Dec; 149(12):6092-102. PubMed ID: 18687772
[TBL] [Abstract][Full Text] [Related]
17. Osteogenic effect of Drynariae rhizoma extracts and Naringin on MC3T3-E1 cells and an induced rat alveolar bone resorption model.
Chen LL; Lei LH; Ding PH; Tang Q; Wu YM
Arch Oral Biol; 2011 Dec; 56(12):1655-62. PubMed ID: 21764032
[TBL] [Abstract][Full Text] [Related]
18. A novel flavonoid, 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats.
Sharan K; Swarnkar G; Siddiqui JA; Kumar A; Rawat P; Kumar M; Nagar GK; Manickavasagam L; Singh SP; Mishra G; Wahajuddin ; Jain GK; Maurya R; Chattopadhyay N
Menopause; 2010; 17(3):577-86. PubMed ID: 20393370
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
[TBL] [Abstract][Full Text] [Related]
20. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
